News & Views
-
On the Horizon: Europe’s next round of science fundingOctober 2011 (Vol. 5 | No. 5 | Pages 395-398)
-
UK’s adopts systematic approach to personalised cancer medicineJune 2011 (Vol. 5 | No. 3 | Pages 217-219)
-
Protein Shakes – the future is not here yet for proteomic–based companion diagnostics, but it's comingJune 2011 (Vol. 5 | No. 3 | Pages 220-223)
-
The cost of hope: Doctors weigh the benefits of new drugs against sky-high costsJune 2010 (Vol. 4 | No. 3 | Pages 301-303)
-
New era in metastatic melanomaApril 2010 (Vol. 4 | No. 2 | Pages 91-97)
-
The unified approach: Meeting the cancer challenges of the next decadeFebruary 2010 (Vol. 4 | No. 1 | Pages 1-8)
-
The US comprehensive cancer centers in perspectiveFebruary 2010 (Vol. 4 | No. 1 | Pages 9-11)
-
Cancer policy in the Obama administrationDecember 2009 (Vol. 3 | No. 5 | Pages 382-385)
-
Putting Europe on the scientific mapDecember 2009 (Vol. 3 | No. 5 | Pages 386-388)
-
Tailoring cancer therapy – Validating basic science with the ‘supertrial’December 2009 (Vol. 3 | No. 5 | Pages 389-391)
-
An interview with Alexander EggermontJune 2009 (Vol. 3 | No. 3 | Pages 188-191)
-
Profile: Professor John MendelsohnApril 2009 (Vol. 3 | No. 2 | Pages 88-90)
-
The Bayh–Dole Act: A model for promoting research translation?April 2009 (Vol. 3 | No. 2 | Pages 91-93)
-
Profile: Professor Axel UllrichFebruary 2009 (Vol. 3 | No. 1 | Pages 3-4)
-
Turning the Stockholm Declaration into reality: Creating a world-class infrastructure for cancer research in EuropeFebruary 2009 (Vol. 3 | No. 1 | Pages 5-8)
-
The flat-funding years and the National Cancer Institute: Consequences for cancer researchDecember 2008 (Vol. 2 | No. 4 | Pages 290-292)
-
Gender bias remains prevalent in the biological sciencesDecember 2008 (Vol. 2 | No. 4 | Pages 293-295)
-
Inside the European Science FoundationOctober 2008 (Vol. 2 | No. 3 | Pages 197-199)
-
Patient organisations aim for greater collaborationOctober 2008 (Vol. 2 | No. 3 | Pages 200-202)
-
Will the Innovative Medicines Initiative really deliver innovative medicines?October 2008 (Vol. 2 | No. 3 | Pages 203-205)
-
American Society of Clinical Oncology's 2008 Gastrointestinal Cancers Symposium (ASCO GI), January 25–27, 2008, Orlando, FloridaJune 2008 (Vol. 2 | No. 1 | Pages 5-7)
-
The Stockholm declaration signals a cultural change in Europe's approach to cancer research. An interview with Ulrik RingborgJune 2008 (Vol. 2 | No. 1 | Pages 8-9)
-
Budapest hosts historic Breast Cancer Global SummitApril 2008 (Vol. 1 | No. 4 | Pages 374-375)
-
News from the 2007 San Antonio Breast Cancer SymposiumApril 2008 (Vol. 1 | No. 4 | Pages 376-378)
-
49th Annual Meeting of American Society of Hematology (Atlanta, Georgia, 8–11 December)April 2008 (Vol. 1 | No. 4 | Pages 379-383)
-
Patient advocacy groups: Empowering patients in their fight against cancerDecember 2007 (Vol. 1 | No. 3 | Pages 252-254)
-
Infrastructure for translational research in AsiaDecember 2007 (Vol. 1 | No. 3 | Pages 255-257)
-
News from ECCO: ECCO 14, The European Cancer Conference was held in Barcelona, Spain, 23–27 September 2007. Report by Janet FrickerDecember 2007 (Vol. 1 | No. 3 | Pages 258-262)
-
Cancer research funding in USASeptember 2007 (Vol. 1 | No. 2 | Pages 128-130)
-
Cancer research funding in EuropeSeptember 2007 (Vol. 1 | No. 2 | Pages 131-134)
-
Cancer research funding in AsiaSeptember 2007 (Vol. 1 | No. 2 | Pages 135-137)
-
Translational cancer research in EuropeJune 2007 (Vol. 1 | No. 1 | Pages 8-10)
-
Translational cancer research in the USAJune 2007 (Vol. 1 | No. 1 | Pages 11-13)
